Halal Nutraceuticals and Vaccines Market by Type [Dietary Nutraceutical and Vaccines], Application [General Well-Being, Immune & Digestive Health, Heart Health, Bone & Joint Health, Weight Loss and Sports Nutrition] – Global Analysis & Forecast 2021-2031
Clairvoyance Research conducted an in-depth market analysis study of the global halal nutraceuticals and vaccines market. According to the study, the market was valued at ~US$ 46.6 billion in 2020. The market is expected to witness a CAGR of ~8.0% from 2021 to 2031.
Rising Muslim population coupled with their demand for halal products, growing awareness for the healthy lifestyle and increasing initiatives to promote halal products development are some of the pivotal factors propelling the growth of the halal nutraceuticals and vaccines market. However, lack of universally acceptable international standards for halal products is likely to hamper the growth of the market to a certain extent.
With an aim to fast-track the development of halal nutraceuticals & vaccines and to meet the needs of the Muslim population, several initiatives such as investments, providing necessary grants, permissions, clearances & approvals have been instigated by various organizations and government agencies across the world. For instance, in Dec 2017, Malaysian healthcare company Pharmaniaga planned to spend 100 million ringgit ($24.6 million) over three years to establish a plant to manufacture halal vaccines.
According to population forecasts by the Pew Research Center’s Forum on Religion & Public Life in 2017, the world’s Muslim population is predicted to increase by 70%, rising from 1.8 billion in 2015 to 3 billion by 2060. With the rise in the global Muslim population especially in Middle East and Asia-Pacific region, the demand for halal product that meet the manufacturing standards of Islamic law is constantly increasing. This in turn is expected to boost the growth of the market.
Demand for nutraceuticals and sports supplements are increasing day by day owing to increase in health awareness. New formulations are constantly being developed to meet increasing demand of consumers. Gelatin is a widely used key ingredient in capsules for prescription drugs and vitamin supplements. Globally, gelatin is derived mostly from bovine and pork. About 44% of global gelatin is derived from pork. Porcine nature of gelatin is a major concern to Muslim consumers. This in turn necessitates the demand for production of halal gelatin. Halal gelatin is produced from the bones & hides of halal slaughtered animals (cattle) and is becoming increasingly important in the pharmaceutical sector in the emerging markets of the Asia-Pacific region that have a large Muslim population. Therefore, increase in demand for halal certified health supplements is expected to boost the market.
However, lack of universally acceptable international standards for halal products may hamper the growth of market to a certain extent. Halal certification is a necessary step to address Muslim needs, but remains a challenging, complex process. Globally, there are more than 300 officially recognized halal certifiers. The lack of commonly accepted standards among global certification bodies has resulted in duplicated certification costs and added complexity.
The Rest of the World (ROW) region is expected to be the fastest growing halal nutraceuticals and vaccines market. About 25%-27% of the world’s total Muslims, resides in this region, making it the 2nd largest Muslim population-based region, which plays an important role in adoption of halal nutraceuticals and vaccines products in this region.
The halal nutraceuticals and vaccines market is marked by presence of prominent players such as Chemical Company of Malaysia Bhd., Abbott, Amway Corp, Agropur, NoorVitamins, Evonik, PT Kalbe Farma Tbk., Pharmaniaga Berhad, Divi's Nutraceuticals and Nutraleya. Other players operating in the market are AJ Biologics Sdn Bhd, Hak Cipta, Kotra Pharma (M) Sdn Bhd, Sky Resources Sdn. Bhd., Herbalife International of America, Inc., among others.
About Us
Clairvoyance Research is a leading market research and consulting firm, based out in Kolkata, India. Our research solutions are structured around the following verticals: Healthcare (Medical Devices, Biotechnology, Healthcare IT, Pharmaceuticals, and Others), Food & Beverage, Consumer Goods, Automotive & Transportation, Chemicals & Materials & Others.
Our main offerings are syndicate reports and consulting assignments – We track a number of verticals and strategically publish syndicate reports on topics that have traction in the market. Over the years, we have developed a forte in executing consulting assignments – Clairvoyance Research has been a trusted partner to over 300 global organizations including Fortune 500 companies. We partner with clients from across the globe to identify their highest-value opportunities, address their most critical challenges, and transform their enterprises. We have a rich pool of clientele spanning leading medical device/biotechnology/healthcare IT/pharmaceutical companies, IT/FMCG/automotive/food & beverage companies, consulting companies, private equity firms, venture capitalists, investment banks, government bodies, academic/research institutes, and universities.
We internally house one of the best talents in the industry – Industry Veterans [Subject Matter Experts (SMEs), Key Opinion Leaders (KOLs)] from different verticals with a profound experience of several decades are there on our panel. At each stage of the study, these experts add value to our reports and consulting assignments. We nurture crème de la crème resources; our analysts/consultants come from robust educational backgrounds. The rich pool of experts and analysts/consultants at Clairvoyance Research ensures that the final research study is accurate, universally accepted, and of the highest quality.
Contact Us
Website: www.clairvoyanceresearch.com
Contract Research, Development and Manufacturing (CRDMO) provides a fully integrated suite of end-to-end solutions for discovery, development, and manufacturing to meet all future market demands.
Cell and gene therapy (CGT) companies partner with CGT CDMOs to get support on discovery, preclinical, clinical stages, CGT product development, manufacturing, and commercial manufacturing.
A contract research organization (CRO) also known as a clinical research organization, is an organization that provides services to pharmaceutical, biotechnology, and medical device companies.
Wearable medical devices are electronic devices that are designed to collect the data of users' personal health and exercise. It offers a convenient means of monitoring many physiological features,...
A MedTech CDMO is a company that serves other companies in the medical device industry on contract basis and provides comprehensive services ranging from design & development, prototyping, tooling,...
Sleep apnea is a condition where breathing is interrupted during sleep. It is considered a serious sleep disorder in which breathing repeatedly stops and starts.
Telehealth is a broader array of digital healthcare activities & services and can be defined as distribution of health-related services & information including medical care, provider & patient educ...
Femtech is a term applied to a category of software, diagnostics, products and services that focus on women's health.
Remote patient monitoring (RPM) is a subset of telehealth. It is a technology that enables monitoring of patients outside of conventional clinical settings.
Micro-catheters are a broad term, often used to describe thin wall, small diameter catheters and delivery devices used in minimally invasive applications. Its small build makes it ideal for navigat...
3D printing also known as additive manufacturing is a process of making three dimensional solid objects from a CAD model or a digital 3D model. The term "3D printing" can refer to a variety of proc...
Hemophilia is a rare inherited bleeding disorder in which the blood does not clot properly which leads to spontaneous bleeding as well as bleeding following injuries or surgery. Blood contains prot...
The term halal is particularly associated with Islamic dietary laws and especially meat processed & prepared in accordance with those requirements. Halal is an Arabic word that means permissible. H...
Urinalysis is a test & analysis of urine to detect and manage a wide range of disorders, namely urinary tract infections, kidney disease and diabetes, among others. It includes a group of physical,...
Allergy is an exaggerated reaction by the immune system in response to exposure to certain foreign substances. These foreign substances are called as allergens and includes pollens, dust mites, mol...
Micro-catheters are a broad term, often used to describe thin wall, small diameter catheters and delivery devices used in minimally invasive applications. Its small build makes it ideal for navigat...
Remote patient monitoring (RPM) is a subset of telehealth. It is a technology that enables monitoring of patients outside of conventional clinical settings.
Femtech is a term applied to a category of software, diagnostics, products and services that focus on women's health.
Telehealth is a broader array of digital healthcare activities & services and can be defined as distribution of health-related services & information including medical care, provider & patient educ...
Sleep apnea is a condition where breathing is interrupted during sleep. It is considered a serious sleep disorder in which breathing repeatedly stops and starts.
A MedTech CDMO is a company that serves other companies in the medical device industry on contract basis and provides comprehensive services ranging from design & development, prototyping, tooling,...
Wearable medical devices are electronic devices that are designed to collect the data of users' personal health and exercise. It offers a convenient means of monitoring many physiological features,...
A contract research organization (CRO) also known as a clinical research organization, is an organization that provides services to pharmaceutical, biotechnology, and medical device companies.
Cell and gene therapy (CGT) companies partner with CGT CDMOs to get support on discovery, preclinical, clinical stages, CGT product development, manufacturing, and commercial manufacturing.
Contract Research, Development and Manufacturing (CRDMO) provides a fully integrated suite of end-to-end solutions for discovery, development, and manufacturing to meet all future market demands.